Clinical trial
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related…
NCT00003207 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00003207 |
|---|---|
| Title | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers |
| Official title | Phase I Study on Doxil and SDZ PSC 833 in the Treatment of AIDS-Associated Kaposi's Sarcoma and Other Advanced Malignancies |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | pegylated liposomal doxorubicin hydrochloride, PSC 833 |
| Enrollment | 14 |
| Start date | Mar 1, 1998 |
| Primary completion | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Apr 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: